TSS Welcomes Gustaf Rasin as New Chief Operations Officer

Profile photo of Gustaf Rasin, new Chief Operations Officer at TSS.
Document

Go to document
TSS, a prominent provider of temperature monitoring solutions, is delighted to announce the appointment of Gustaf Rasin as its new Chief Operations Officer (COO). Gustaf Rasin will play a vital role in refining the company's operational workflows and fostering its growth and environmental sustainability vision.
PRESS RELEASE 2 November 2023

Gustaf Rasin brings a wealth of experience and knowledge to the position, holding an MSc in Industrial Engineering and Logistics from the esteemed KTH Royal Institute of Technology. His recent roles as a Management Consultant have showcased exceptional leadership within various capacities in Life Science and Med-Tech organizations.

‍

A promising era of operations development and strategic progress for TSS

‍

Gustaf Rasin, commenting on his new role, expressed his eagerness to contribute to the company's evolution and to help shape its future. TSS is a forward-thinking company that emerges from the existing framework, bringing with it all the implications of change and development. He also cited the collaborative spirit of his colleagues and the company culture as significant driving forces.  

TSS eagerly anticipates the strategic and dynamic contributions Gustaf Rasin will bring to the company as Chief Operations Officer. His appointment signals a promising era of operations development and strategic progress for TSS.

You may also be interested in

A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read moreDownload Whitepaper

Covid-19 situation

The effects of the Covid-19 outbreak are escalating daily and is first and foremost a human tragedy, affecting hundreds of thousands of people.
Read moreDownload Whitepaper
A collage illustrating three steps for clinical trials: vaccine vials, data analysis, and a healthcare professional.

3 steps to accelerate Decentralized trials & Release to patients

Seamless monitoring of direct-to-patient shipments within an end-to-end calculation engine enables a digital release in patient's homes. Site centric technology also allows for a decentralized and proactive approach, reducing waste. Furthermore, digitalizing temperature management end-to-end enables a faster release of products for all types of trials and creates a foundation for successful decentralized drives.
Read moreDownload Whitepaper

You may also be interested in

TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona

TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read more

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.